Filing Flows › ASP Isotopes (ASPI) › Q1 2026 › vs Q4 2025
ASP Isotopes (ASPI) Q1 2026 vs Q4 2025 (quarter over quarter)
ASP Isotopes's revenue fell $12.5M (-75%) from $16.7M in Q4 2025 to $4.2M in Q1 2026.
ASP Isotopes, Q1 2026: revenue $4.2M (+279% year over year), operating margin -595.4%, net loss $7.1M, operating cash flow −$17.8M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $4.2M | $16.7M | −$12.5M | -75% |
| Other income, net | $17.7M | −$38.1M | $55.9M | — |
| Income tax benefit | $31K | −$184K | $215K | — |
| Net loss | $7.1M | $63.3M | −$56.2M | -89% |
| Costs & expenses | $29.1M | $80.0M | −$50.9M | -64% |
| Operating costs | $29.1M | $41.7M | −$12.6M | -30% |
| Cost of revenue | $2.5M | $14.6M | −$12.1M | -83% |
| Research & development | $5.3M | $6.8M | −$1.6M | -23% |
| General & admin | $21.3M | $17.5M | $3.8M | +21% |
| Operating cash sources | $25.2M | $24.0M | $1.2M | +5% |
| Depreciation & amortization | $3.1M | $937K | $2.1M | +226% |
| Share-based compensation | $4.4M | $5.2M | −$809K | -15% |
| Cash used in operations | $17.8M | $17.9M | −$91K | -0.5% |
| Net loss absorbed | $7.1M | $63.3M | −$56.2M | -89% |
| Working capital & other | $18.1M | −$39.3M | $57.4M | — |
Questions
How much did ASP Isotopes's revenue grow quarter over quarter in Q1 2026?
ASP Isotopes's revenue fell $12.5M (-75%) from $16.7M in Q4 2025 to $4.2M in Q1 2026.